P.P.RosenzweigP.P. i inni, A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers, „Human Psychopharmacology”, 1 (17), 2002, s. 1–13, DOI: 10.1002/hup.320, PMID: 12404702.
Atheir I.A.I.AbbasAtheir I.A.I. i inni, Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo, „Psychopharmacology”, 205 (1), 2009, s. 119, DOI: 10.1007/s00213-009-1521-8, PMID: 19337725, PMCID: PMC2821721.
A.M.A.M.MortimerA.M.A.M., Atypical Antipsychotics as First-Line Treatments for Schizophrenia: Advantages for Stakeholders in the UK Healthcare System, „Disease Management & Health Outcomes”, 3 (12), 2004, s. 169–179, DOI: 10.2165/00115677-200412030-00003.
P.P.RosenzweigP.P. i inni, A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers, „Human Psychopharmacology”, 1 (17), 2002, s. 1–13, DOI: 10.1002/hup.320, PMID: 12404702.
Atheir I.A.I.AbbasAtheir I.A.I. i inni, Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo, „Psychopharmacology”, 205 (1), 2009, s. 119, DOI: 10.1007/s00213-009-1521-8, PMID: 19337725, PMCID: PMC2821721.
G.K.G.K.IsbisterG.K.G.K. i inni, Amisulpride deliberate self-poisoning causing severe cardiac toxicity including QT prolongation and torsades de pointes, „The Medical Journal of Australia”, 7 (184), 2006, s. 354–356, PMID: 16584372.
